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Abstract
 
To study homeostasis of peripheral B lymphocytes in the absence of B cell influx from the
bone marrow, we generated a mouse mutant in which the recombination-activating gene
(
 
RAG)-2
 
 can be inducibly deleted. When 
 
RAG-2
 
 was deleted at the age of 8–10 wk, splenic
naive follicular B cells were gradually lost over a year of observation, with a half-life of 
 
 
 
4.5
mo. By contrast, the pool of marginal zone B cells in the spleen and of B-1 cells in the perito-
neal cavity were kept at normal level. In lymph nodes, 
 
 
 
90% of the B cells were lost within 4
mo, and B cell numbers remained constant thereafter. Mice in which 
 
RAG-2
 
 was deleted at
birth maintained a small population of activated B cells with an increased proportion of mar-
ginal zone B cells. Additionally, an increase of the pool of IgM secreting cells and B-1a cells
was observed.
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Introduction
 
In mouse and man, B cells are continuously generated from
B cell progenitors over lifetime, with the fetal liver and,
from around birth on, the bone marrow (BM)
 
*
 
 as the main
sites where this process takes place. The immature B cells
generated in the BM emigrate into the peripheral immune
system and give rise to a heterogeneous population of pe-
ripheral B cells including naive, memory and plasma cells
(1). In terms of their anatomical location and surface mark-
ers, the B cell population in the periphery consists of recir-
culating IgM
 
low
 
IgD
 
high
 
CD21
 
int
 
CD23
 
high
 
 cells located in
follicles in spleen and lymph nodes, and IgM
 
high
 
IgD
 
low
 
CD21
 
high
 
CD23
 
low
 
 non-recirculating cells enriched
mainly in the marginal zone (MZ) of the spleen (2, 3). Fol-
licular (FO) B cells in the spleen account for 80–90% and
MZ B cells for 5–10% of the splenic B cells in an adult
mouse (4). Another B cell subset, consisting of the so-called
B-1 cells, has self-renewing capacity and predominates in
the peritoneal and pleural cavities (5). Recent data on the
function of MZ B cells (6–8) and B-1 cells (9, 10) suggest
that these cells provide a first line of defense against anti-
gens in the blood, and in the peritoneal and pleural cavities,
respectively. FO B cells are involved in T cell–dependent
antibody responses, in which memory and plasma cells are
generated (7).
About 1–2 
 
 
 
 10
 
7
 
 immature B cells are generated daily in
the adult murine BM (11). Of these, only 3% enter the
pool of mature B cells of the various subsets (12). Periph-
eral B cell pools represent dynamic, yet stable compart-
ments where the input contributed by BM immigrants and
antigen driven cell proliferation is balanced by apoptosis
and terminal differentiation (13).
For an understanding of this homeostatic control it is of
critical importance to determine the life spans of B cells of
various subsets under physiological conditions. It is there-
fore not surprising that B cell life spans have been the sub-
ject of many investigations in the past. However, while it is
generally agreed that newly generated immature B cells in
adult mice have life spans of 
 
 
 
3-4 d (12, 14), the life spans
of mature B cells are still controversial. Experiments based
on (a) adoptive transfer of LPS-reactive B cells into LPS-
nonreactive recipient mice (15); (b) the ablation of cycling
B cell precursors with cytotoxic drugs which selectively kill
cycling cells (16, 17); and (c) induction of BM aplasia using
a radioactive strontium isotope, 
 
89
 
S (18) support the hy-
pothesis that most mature B cells have a life span of just a
few days (13). In contrast, experiments in which B cell de-
velopment was blocked by anti–IL-7 (19), or anti–IL-7 re-
ceptor antibodies (20) or cells were labeled by [
 
3
 
H]thymi-
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dine (21–23) or bromo deoxyuridine (BrdU) in vivo (24–
26) lead to the conclusion that the majority of splenic B
cells can persist for several weeks or months.
To further clarify this matter and to extend the analysis
to the various subsets of mature B cells, we have now
generated a transgenic mouse strain in which B cell de-
velopment can be blocked permanently at any stage of
development under quasi-physiological conditions. To
achieve this goal we made use of the fact that both B and
T cell development critically depend on the somatic as-
sembly of Ig or T cell receptor variable region gene seg-
ments, called V, D, and J, by a process known as V(D)J
recombination (27). V(D)J recombination is mediated by
the products of the recombination-activating genes
 
RAG-1
 
 and 
 
RAG-2
 
 (28). Consequently, in 
 
RAG-1–
 
 or
 
RAG-2
 
–deficient mice B and T cell development are
blocked at an early progenitor stage (29, 30). Induced in-
activation of 
 
RAG-1
 
 or 
 
RAG-2
 
 in B and T cell progeni-
tors in the BM can thus be expected to lead to a block in
B and T cell generation. Using conditional gene target-
ing (31), we established a transgenic mouse strain in
which 
 
RAG-2
 
 can be inducibly and efficiently inacti-
vated whenever desired. In the present paper, we de-
scribe this experimental system and use it to study the
maintenance and differentiation of the various peripheral
B cell subsets in intact, healthy animals, in the absence of
B cell influx from the BM, i.e., a situation in which B
cell life spans should be maximized.
 
Materials and Methods
 
Construction of the RAG-2 Targeting Vector.
 
A 
 
RAG-2
 
 con-
taining genomic clone from the 129-mouse strain was isolated by
screening a 129Sv genomic library by PCR (Genome Systems).
The coding sequence for the RAG-2 protein lies within exon 3
of the 
 
RAG-2
 
 gene (28). Therefore, the targeting strategy was to
flank this exon by 
 
loxP
 
 sites. The 6-kb XbaI fragment containing
the entire RAG-2 coding exon and the 4.8-kb XbaI fragment at
the 3
 
 
 
end of 
 
RAG-2
 
 gene were cloned by standard cloning tech-
niques into pGEM 
 
loxP
 
 and pBluscript-
 
tk
 
, respectively (see Fig. 1
A). As a selection marker, the neomycin resistance gene flanked
by two 
 
loxP
 
 sites was cloned into the unique SalI site in intron II.
The thymidine kinase (
 
tk
 
) gene was added to the 3
 
 
 
 ends of the
vectors (see Fig. 1 A).
 
Generation of RAG-2 
 
fl/fl
 
 Mice.
 
The experimental procedures
used for the culture, transfection, and selection of embryonic
stem (ES) cells were as described previously (32). Bruce-4 ES cells
(1.5 
 
 
 
 10
 
7
 
) (33) derived from C57BL/6 mice were transfected by
electroporation with a PvuI-linearized targeting vector (40 
 
 
 
g).
After double selection with G418 (350 
 
 
 
g/ml) and Gancyclovir
(2 
 
 
 
M) for around 10 d, colonies were picked and screened for
homologous recombination of the 
 
RAG-2
 
 floxed allele by
Southern blotting analysis as shown in Fig. 1 B. BamHI-digested
genomic DNA from double resistant colonies were hybridized
with external probe (a) to yield bands of 17 kb against 12 kb for
wild-type and targeted loci, respectively. To screen for clones
that had cointegrated the third 
 
loxP
 
 site, BamHI-digested ge-
nomic DNA from homologous recombinants were hybridized
with internal probe (b). The presence of a 1.4 kb band indicates
the third 
 
loxP
 
 cointegration event.
To delete the neomycin resistance gene in vitro, targeted ES
cell clones were transiently transfected with a Cre-encoding plas-
mid. DNA from neomycin-sensitive clones were digested with
HindIII and hybridized with probe (c). Bands of 6 kb only and 6
kb against 4.6 kb indicate targeted loci with total deletion and the
neomycin resistance gene deletion, respectively (Fig. 1 B). To
confirm this, DNA from neomycin-sensitive clones were di-
gested with StuI and hybridized with probe (a). The size of the
bands was 16 kb against 12 kb for the neomycin resistance gene
deletion and 16 kb only for total deletion. Two targeted ES cell
clones were injected into 3.5-d blastocysts harvested from CB.20
or BALB/c mice, and the blastocysts transferred to the uteri of
pseudopregnant (C57BL/6 
 
 
 
 BALB/c) F1 foster mothers. Male
chimeric mice were mated with C57BL/6 females to generate
mutant offspring on the C57BL/6 genetic background. Germline
transmission was scored by coat color and Southern blotting anal-
ysis of tail DNA.
To establish a system of inducible 
 
RAG-2
 
 deletion, mice with
the 
 
RAG-2
 
 floxed allele (
 
RAG-2
 
fl/fl
 
) were bred with Mx-cre
transgenic mice in which the cre transgene is under the control of
the type I IFN-inducible Mx promoter (34). The Mx-cre trans-
genic mice used in our experiments had been backcrossed to
C57BL/6 for at least five generations. All mice used in this study
were bred and maintained in a conventional animal facility in the
Institute for Genetics, Cologne. All animal studies were approved
by the institutional review board.
 
Induced Deletion of RAG-2.
 
To induce Cre expression and
subsequent deletion of 
 
RAG-2
 
, mice at 8–10 weeks of age with
the genotype of 
 
RAG-2
 
fl/del
 
, Mx-cre were given three doses of
Poly(I)·Poly(C) (400 
 
 
 
g/dose; Amersham Pharmacia Biotech) by
intraperitoneal injection on days 0, 3, and 6 and analyzed at vari-
ous time points thereafter. The animals used in the BrdU labeling
experiments had been treated with four doses of Poly(I)·Poly(C)
(100 
 
 
 
g/dose) at 1 d intervals. In newborn or 2-wk-old mice,
 
RAG-2
 
 deletion was induced by three doses of type I IFN injec-
tion (10
 
6 
 
U/dose for neonates and 2 
 
 
 
 10
 
6 
 
U/dose for 2-wk-old
mice) given at 2-d intervals. To measure the degree of 
 
RAG-2
 
gene deletion, cells were isolated from different organs to prepare
genomic DNA for Southern blotting.
 
BM Transfer.
 
For reconstitution assays, single cell suspensions
were prepared from the BM and B and T cells were depleted by
MACS (Miltenyi Biotec), using anti-IgM and anti-Thy1.2 mAb-
coupled magnetic beads. Purified BM cells (5 
 
 
 
 10
 
6
 
) were in-
jected intravenously into 9–16-wk-old C57BL/6, 
 
RAG-1
 
–/–
 
mice after irradiation (400 rad).
 
Flow Cytometry.
 
Single-cell suspensions were prepared from
spleen, superficial inguinal lymph nodes, BM (one femur), and
peritoneal cavity of 
 
RAG-2
 
fl/del
 
, Mx-cre, or littermate controls.
10
 
6
 
 cells were stained with fluorochrome- (FITC, PE, or Cy-
chrome) or biotin-conjugated monoclonal antibodies for flow
cytometric analysis on a FACSCalibur™ (Becton Dickinson).
Streptavidin-Cychrome or streptavidin-Alexa were used to reveal
biotinylated antibodies. The following homemade mAbs were
used: R33–24–12 (anti-IgM), F30–1 (anti-heat shock antigen
[HSA]), 7G6 (anti-CD21), 1.3–5 (anti-IgD), RA3–6B2 (anti-
B220), M5–114 (anti-MHC class II). mAbs against CD3, CD4,
CD5, CD8, CD19, CD23, CD25, CD69, MHCII, CD62L, and
CD86 were purchased from BD PharMingen.
 
Immunohistology.
 
Spleens were embedded in OCT and fro-
zen on dry ice. Frozen sections were cut, air-dried, and fixed
with cold (
 
 
 
20
 
 
 
C) acetone. For double immunostaining, sec-
tions were rehydrated in PBS and stained. We used biotin-conju-
gated anti-MadCAM (Southern Biotechnology Associates, Inc.) 
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plus peroxidase-labeled anti-IgM (goat anti–mouse; Sigma-
Aldrich) and MOMA-1 (rat, IgG2a, specific for mouse splenic
metallophilic macrophages; Dianova) plus biotin-conjugated rab-
bit anti-IgG plus peroxidase-coupled anti-IgM to locate the MZ
and FO B cells. After washing, bound peroxidase was revealed by
3-amino-9-ethyl carbazole (Sigma-Aldrich), and biotin by alka-
line-phosphatase substrate kit III/blue (Vector Laboratories).
 
BrdU Labeling and Cell Cycle Analysis.
 
Mice were fed with
BrdU (Sigma-Aldrich) in the drinking water (1 mg/ml) for 3 d.
Single cell suspensions from spleens were stained with IgM-allo-
phycocyanin (APC), CD23-PE, and CD21-bio and sorted into
MZ and FO B cells by FACS
 
®
 
. The sorted cells were fixed in
70% cold ethanol; their DNA denatured with 2 M HCl and
stained with FITC conjugated ant-BrdU antibody (Becton Dick-
inson). The cells were then washed twice with PBS and resus-
pended in 500 
 
 
 
l of PBS containing 5 
 
 
 
g/ml of propidium io-
dide (Sigma-Aldrich). The fraction of BrdU-labeled cells in each
sorted cell population and DNA content of single cells, excluding
doublets, was analyzed on FACS
 
®
 
.
 
ELISA and Enzyme-linked Immunospot. 
 
Serum Igs levels were
measured by ELISA as described (35). The enumeration of IgM
and IgG3 secreting cells was done by enzyme-linked immuno-
spot (ELISPOT) according to Czerkinsky (36).
 
Results
 
Generation and Characterization of a Mouse Strain Allowing
Conditional Inactivation of RAG-2.
 
The gene targeting
strategy and screening of recombinant ES cells by Southern
blotting are shown in Fig. 1, A and B, respectively. The
conditional 
 
RAG-2
 
 allele (RAG-2
 
fl
 
) was transmitted into
the C57BL/6 germline and the mutant mice were ana-
lyzed. B cell lymphopoiesis in the BM of 
 
RAG-2
 
fl/fl
 
 mice
was normal, and the size of the peripheral B cell pool was
comparable to that of wild-type mice, indicating no inter-
ference with 
 
RAG-2
 
 expression by the insertion of the two
 
loxP
 
 sites (data not shown). To generate mice homozygous
for 
 
RAG-2
 
 deletion (
 
RAG-2
 
del/del
 
), 
 
RAG-2
 
fl/fl
 
 mice were
crossed to the 
 
deleter
 
 strain, which allows ubiquitous dele-
tion of 
 
loxP
 
-flanked gene segments including germ cells
Figure 1. Generation of
RAG-2fl/  mice (A) targeting
scheme. (1) Restriction map of
the RAG-2 locus. Probes used to
verify targeting events are indi-
cated as a, b, and c together with
the expected sizes of the restric-
tion fragments. The restriction
sites of XbaI (X), BamHI (B),
HindIII (H), and StuI (S) are in-
dicated. (2) Targeting vector
construction. The loxP flanked
neomycin resistance gene was
inserted into a unique SalI site. A
third  loxP site was introduced
downstream of exon 3. In this
way, the entire coding sequence
for RAG-2 protein was flanked
by  loxP sites (triangles). The
structure of the targeted RAG-2
locus (3), the targeted locus after
removal of the neomycin resis-
tance gene (4), and the locus fol-
lowing deletion of the loxP-
flanked exon 3 (5) are shown,
including sizes of diagnostic re-
striction fragments. (B) South-
ern blot analysis of ES cell
clones. Genomic DNA from
wild-type Bruce-4 cells and
clones 6, 101, and 292 were di-
gested with BamHI and hybrid-
ized with probe (a) to verify the
targeting event or with probe (b)
to detect cointegration of the
third loxP site. Probe (c) together
with HindIII digestion and
probe (a) together with StuI di-
gestion were used to distinguish subclones that had deleted only the neomycin resistance gene or the neomycin resistance gene and the entire loxP
flanked fragment after transient transfection of the recombinants with a Cre-expressing plasmid. Numbers on the left side of the blots indicate fragment
sizes in kb. (C) Block of B cell development upon the induction of RAG-2 deletion. Adult mice carrying or not carrying the Mx-cre transgene were in-
jected with Poly(I)·Poly(C) and BM and spleen cells analyzed by FACS® 2 wk later. Numbers indicate the percentage of total lymphocytes. (D) BM cells
of Poly(I)·Poly(C) treated RAG-2fl/del, Mx-cre mice have no B cell reconstitution potential as shown by transfer into sublethally irradiated RAG-1 / 
mice. A flow cytometric analysis of spleen cells isolated from recipients that had received control (left) or RAG-2–deficient (right) BM cells 4 wk earlier
is depicted. 
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(37). B and T cell development in 
 
RAG-2
 
del/del
 
 mice was
blocked at the pro-B and the pro-T cell stages, producing
the phenotype of classical RAG-1 and RAG-2 knockout
mice (29, 30; data not shown).
Mice of the genotype RAG-2fl/del, Mx-cre, in which
RAG-2 deletion can be efficiently induced by IFN or its
inducer, Poly(I)·Poly(C) (34), were used in our further
experiments. 2 wk after intraperitoneal injection of
Poly(I)·Poly(C) into adult RAG-2fl/del, Mx-cre mice,
slightly fewer BM cells were recovered from these ani-
mals than from similarly treated littermate controls. Gat-
ing on the IgM-negative population, the B220lowCD43 
pro-B cell compartment in the experimental animals was
comparable to that of the controls, whereas B220low
CD43  pre-B cells were essentially absent, indicating a
block of B cell development at the pro-B cell stage (Fig.
1 C). B220lowIgM  immature B cells were at background
levels, while B220highIgM  mature B cells were not af-
fected. Similar to B cell development in the BM, T cell
development in the thymus was blocked at the pro-T
cell stage upon induction of RAG-2 deletion (data not
shown). In agreement with the short life span of imma-
ture B cells (12, 14), the IgM HSAhigh immature B cell
compartment in the spleen of the Poly(I)·Poly(C) treated
mutants was reduced to background levels (see Fig. 1 C;
the few IgM HSAhigh cells in the spleens of the mutants
were mostly CD21  and therefore presumably MZ B
cells). As in adult mice, B cell development was also
blocked at the pro-B cell stage in mice in which RAG-2
was deleted at birth or at the age of 2 wk (data not
shown). In these mice as well as in those treated with the
inducer at adult age, the block of B cell development as
depicted in Fig. 1 C was maintained over the entire pe-
riod of observation (see below; data not shown). The de-
letion efficiency of the RAG-2fl allele in the BM as
quantified by Southern blotting analysis was close to
100% both in adult and neonates, whereas it was  90%
in the spleen and cells in the peritoneal cavity (data not
shown).
To verify that the induced block of B cell development
was indeed complete, we reconstituted sublethally irradi-
ated syngeneic RAG-1 /  mice (that lack B and T cells)
with BM cells of 13-wk-old RAG-2fl/del, Mx-cre mice
which had been treated with Poly(I)·Poly(C) at the age of
8 wk. BM cells from similarly treated RAG-2fl/del mice
served as a control. The total number of splenic cells re-
covered 4 wk after transfer was 2.8   106 in recipients re-
constituted with BM from Poly(I)·Poly(C) treated RAG-
2fl/del, Mx-cre mice and 2.2   107 in the controls. As
shown in Fig. 1 D, mice that had received BM cells from
the induced mutants exhibited no detectable reconstitution
for B cells, whereas the controls were fully reconstituted.
Similar results were obtained using BM cells from 19-wk-
old donor mice in which RAG-2 had been inactivated at
birth (data not shown). In both reconstitution experi-
ments, BM cells from two donor mice were individually
tested. In all cases, the donor-derived RAG-2 deletion
could be detected by PCR in the BM and spleen of the re-
cipients, indicating that the donor cells had been accepted
by the latter (data not shown).
Slow Decline and Subsequent Persistence of Peripheral B Cells
in Adult Mice upon Induced Blockade of B Cell Influx from the
BM. The survival kinetics of B cells in the spleen, lymph
nodes, and BM in the absence of new immigrants from the
BM was followed in mice in which RAG-2 was deleted at
the age of 8–10 wk. Compared with the controls, the size
of the B cell pool in the spleen of RAG-2fl/del, Mx-cre mice
was reduced from 67% at week 2 (at which time the imma-
ture cells had disappeared [Fig. 1 C]) to 32% at week 17 af-
ter Poly(I)·Poly(C) injection and subsequently was kept sta-
ble up to 54 wk (Fig. 2 A). In the lymph nodes, the
numbers of B220 IgD  B cells were not reduced during
the first 2 wk, and declined subsequently, with a rapid drop
of cell numbers (from 58 to 11% of the controls) between
week 10 and week 17 after induced RAG-2 deletion (Fig.
2 B). There was no further reduction in B cell numbers in
the lymph nodes between 17 and 54 wk. As shown in Fig.
2 C, the size of the B220highIgM  mature B cell pool in the
BM was reduced by half in comparison to the controls 2
wk after Poly(I)·Poly(C) injection, and subsequently de-
clined slowly over the period of observation, with a half-
life of 156 d. As in the spleen, the reduction of B cell num-
bers during the first 2 wk was mainly due to the loss of
HSAhigh B cells. Taken together, the overall numbers of B
cells in the secondary lymphoid organs of adult mice in the
absence of B cell influx from the BM declined over the first
17 wk and were subsequently maintained for up to 54 wk.
In contrast, the numbers of IgM CD5  B-1a cells in the
peritoneal cavity of the mutants were comparable to those
of the controls (data not shown).
Decline of FO B Cells and Maintenance of MZ B Cells after
RAG-2 Deletion in Adults. MZ B cells are distinguished
from recirculating FO B cells by anatomical location and
phenotypic characteristics. According to the expression
levels of CD21 and CD23, we divided the splenic B cells
into MZ (CD21highCD23low) and FO (CD21intCD23high)
B cells and followed their numbers after induction of
RAG-2 deletion in adult mice. As shown in Fig. 3 A, the
proportion of MZ B cells within the population of surface
IgM-positive cells increased from less than 10% to 17% at
week 2 and  40% at week 31 after RAG-2 deletion,
whereas it was constant in the controls over the same pe-
riod of time. In terms of cell numbers, the MZ B cell pool
in the spleen of the experimental animals was comparable
to that of the controls and stable over 54 wk (Fig. 3 B). In
contrast, the number of FO B cells declined slowly, with a
calculated half-life of 134 d (Fig. 3 B) and thus in reason-
able accord with the decline of recirculating B cells in the
BM (Fig. 2 C).
When B Cell Development Is Blocked at Birth, Small Num-
bers of B Cells Are Maintained, with an Expanded Population of
B-1 Cells in the Peritoneal Cavity and MZ B Cells in the
Spleen. To what extent can the immature B cells present
in newborn mice build a peripheral B cell compartment in
the absence of B cell influx from the BM? When RAG-2
was deleted in newborns by injection of IFN, the animals1155 Hao and Rajewsky
maintained a small population of B cells in spleen and
lymph nodes over long periods of time, but B cell numbers
were far below those developing in the controls (Fig. 2, D
and E). In contrast, the development of B-1a cells
(IgM CD5 ) in the peritoneal cavity was undisturbed, and
from week 8 after IFN injection on, 2 to 3 times more
such cells were recovered from the animals than from con-
trols (Fig. 2 F). Thus, the block of B cell generation at birth
did not perturb the development and expansion of the
B-1a cells, a result that is in line with the earlier findings
showing that B1 cells are self-renewing cells (5).
The MZ in mice usually does not develop until 3 wk of
age (38). All splenic B cells in the newborn mice express
high levels of HSA and have an immature phenotype (data
not shown). We induced RAG-2 deletion in newborn mice
by IFN injection and asked whether B cells in the spleens of
these animals would differentiate into MZ B cells in the ab-
sence of B cell influx from the BM. Surprisingly, some B
cells acquired a MZ B cell phenotype and some a FO B cell
phenotype already 2 wk after RAG-2 deletion, which was
less evident in the age-matched controls (Fig. 3 C). The
percentage of MZ B cells within the population of surface
IgM-positive cells was  25% from week 4 up to week 28
after RAG-2 deletion (Fig. 3 C). In terms of cell numbers,
MZ B cells in the induced RAG-2–deficient mutants in-
creased slightly over time, from  8   105 at week 4 to 2  
106 at week 28 after RAG-2 deletion (Fig. 3 D). The FO B
cells developing in the animals (Fig. 3 C) remained constant
Figure 2. Survival kinetics of B cells in the spleen, lymph nodes, and BM of adult mice after induction of RAG-2 deletion (A–C) or of mice in which
RAG-2 was deleted at birth (D–F). Mice of the genotype of RAG-2fl/del, Mx-cre, and littermate controls were either injected with Poly(I)·Poly(C) at the
age of 8–10 wk or with type I IFN at birth. Cells from spleen, BM, lymph nodes, and peritoneal cavity were isolated at various periods after induced
RAG-2 deletion and analyzed by FACS®. Numbers of B220 IgM  cells in the spleen (A and D); B220 IgD  cells in the lymph nodes (B and E) and
B220highIgM  cells in the BM (C) are plotted against time (weeks) after induction of RAG-2 deletion. The half-life (t1/2) of B220highIgM  cells in the BM
was calculated from a linear regression line (dashed), using Sigma Plot software. Circles represent data from individual mice, open circles representing
controls, and solid circles RAG-2fl/del, Mx-cre mutants. Solid lines connect mean values of each group. A representative flow cytometric analysis of cells
in the peritoneal cavity at the age of 8 wk is shown in F. Numbers are percentages of CD5 IgM  cells in the lymphocyte population.1156 Homeostasis of Peripheral B Lymphocytes
Figure 3. Inactivation of RAG-2 leads to a relative en-
largement of MZ B cell compartment. Analysis of MZ and
FO B cells in the spleen of RAG-2fl/del, Mx-cre, and
RAG-2fl/del control mice at various times after RAG-2 de-
letion at the age of 8–10 wk (A and B) or at birth (C and
D). FACS® profiles were obtained by gating on IgM-posi-
tive cells, and numbers indicate percentages of MZ
(CD21highCD23low) and FO B cells (CD21intCD23high) (A
and C). In C, in the induced mutants, cells falling outside
the corresponding windows represent mainly B-1a cells
(bottom left panel; see text). In B and D, the numbers of
MZ and FO B cells are plotted against time (weeks). The
half-life (t1/2) of FO B cells in the spleen was calculated
from a linear regression line (dashed) as indicated in the
legend to Fig. 2. Solid lines connect mean values.1157 Hao and Rajewsky
in numbers over time (Fig. 3 D). Apart from MZ and FO B
cells, CD5  B cells could be detected in the spleen of the
animals, amounting to 30–50% of the IgM  or CD19 
cells. In absolute numbers, this matches the compartment of
CD5  B cells (B-1a cells) in the spleen of the controls (data
not shown; but see Fig. 3 C, bottom panel).
The relative increase in the MZ B cell pool seen by flow
cytometry was also evident at the level of histology. At the
age of 8–10 wk, an increase in MZ B cells and a decrease in
FO B cells could be observed in histological sections of the
spleen in the mutants, in comparison to controls (Fig. 4).
Peripheral B Cells in Mice in which B Cell Development Was
Blocked at Birth Acquire an Activated Phenotype and Have Pro-
liferative Activity. The small B cell population maintained
in the spleen of animals in which B cell development was
blocked at birth are not only unusual with respect to their
tendency to develop into MZ B cells. These cells also had
increased size and showed an upregulation of activation
markers like CD25, CD69, CD86, and MHC class II when
analyzed at the age of 8 wk (Fig. 5). The activated cells, ir-
respective whether of MZ or FO phenotype, exhibited
substantial proliferative activity, with 10% of MZ B cells
and 7% of FO B cells incorporating BrdU after a 3-d label-
ing period, compared with 16 and 11% in the controls (in
which there is influx of newly generated B cells from the
BM; Fig. 6 A). An analysis of the cells for DNA content
showed that up to 1% of the cells were in the S or G2/M
phase of the cell cycle (Fig. 6 A). These data suggest that a
substantial fraction of the B cells maintained in these ani-
mals in spleen and lymph nodes undergo self-renewal.
However, not all cells may participate in this self-renewal
activity, as BrdU administration for a period of 3 wk re-
sulted in at most one quarter of the cells being labeled (data
not shown).
Figure 4. Enlarged MZs in
spleens of mice with induced
RAG-2 deficiency from birth.
Spleen sections from 8 to 10-
wk-old control (a and c) and
RAG-2fl/del, Mx-cre mice (b and
d) treated with type I IFN at
birth, stained with antibodies
against IgM (red, a to d) for B
cells, MadCAM-1 for cells lining
the marginal sinus (blue, a and b)
and MOMA-1 (blue, c and d)
for metallophilic macrophages.
MZB, marginal zone B cells;
MS, marginal sinus; M, mac-
rophages; F, follicular B cells.
Original magnification:  100.1158 Homeostasis of Peripheral B Lymphocytes
The situation was quite different in mice in which B cell
development had been blocked at the age of 8 wk. When
these animals was fed with BrdU in the drinking water for
3 d, 10 wk after application of Poly(I)·Poly(C), only 1% of
the FO B cells and 2% of the MZ B cells were labeled,
compared with 2 and 3%, respectively, in the controls (Fig.
6 B). According to DNA content, again around 1% of the
cells was in S or G2/M phase of the cell cycle (Fig. 6 B). It
is possible that in these animals the remaining B cells ac-
quire full self-renewing activity only later, when cell num-
bers have dropped to a level comparable to that seen in an-
imals in which B cell development was blocked at an early
stage. In accord with this possibility, when RAG-2 deletion
was induced in adult mice, the B cell acquired an activated
phenotype like the one depicted in Fig. 5 only around 4
mo later (data not shown).
RAG-2 Deletion Induced at Birth Leads to an Increase of Se-
rum IgM Levels and the Numbers of IgM Secreting Cells. The
number of B cells in animals in which RAG-2 was deleted
at birth is less than 10% of the controls (Fig. 2, D and E).
Still, at the age of 8 and 17 wk, serum immunoglobulin
levels in the these mice were close to, and occasionally
even above, those in the controls (Fig. 7, A and B). To un-
derstand this phenomenon, we employed ELISPOT to de-
termine the number of IgM and IgG3 secreting cells in the
spleen and BM of the mice at the age of 8 weeks. As shown
in Fig. 7 C, the total number of IgM secreting cells was
three- to fourfold larger in the induced RAG-2 mutants
than in the controls, and the animals also harbored substan-
tial numbers of IgG3 secreting cells. The antibody secreting
cells may well largely derive from B-1 cells which are
present in these animals in normal numbers and known to
contribute significantly to the production of IgM (39).
Discussion
Approaches to Study the Stability and Self-renewing Potential
of the Peripheral B Cell Pool. A recent review of the litera-
ture on B cell life spans in the mouse (40) documents strik-
ingly to which extent the methods used to approach this
problem determine the experimental outcome. Depending
on whether B cell progenitors were ablated in situ, B cells
were transferred into immunocompetent or immunodefi-
cient, irradiated, or nonirradiated hosts, or the incorpora-
tion of nucleotide analogs or radioactively labeled nucle-
otides into the DNA of B cells was measured, life span
determinations ranged from a few days to several weeks or
months for mature B cells. This complexity is not surpris-
ing given the requirement for the organism to keep the size
of the peripheral B cell pool constant in a first approxima-
tion, although there is continuous but variable loss or ex-
pansion of cells in immune reactions and competition of
the various B cell subsets for space. Therefore, the entry of
newly generated B cells into the peripheral B cell pool
must be carefully controlled and B cell life spans likely de-
pend heavily on the extent to which this homeostatic con-
trol is disturbed by the experimental approach (13).
In previous work we had come to the conclusion that
in intact mice the life span of most mature B cells is in the
order of weeks or months, based on BrdU incorporation
measurements using both direct labeling of the cells and a
pulse-chase protocol (24). We have now attempted to es-
tablish an experimental system in which B cell life spans
can be measured in vivo under conditions under which
they should be maximized by homeostatic control,
namely in the absence of influx of new B cells from the
BM. Such a system would also allow the study of the self-
renewing capacity of the peripheral B cell pool, and it
would be of practical relevance as well, by mimicking sit-
uations in which B cell generation is suppressed, e.g. by
cytotoxic drugs as they are used in the chemotherapy of
tumors.
Earlier attempts in this direction have used chemicals like
Strontium-89 (18), hydroxyurea (15), Gancyclovir in her-
Figure 5. Splenic B cells in mice with induced RAG-2 deficiency from
birth are activated. RAG-2fl/del, Mx-cre mice, and littermate controls
were injected with type I IFN at birth. At the age of 8 wk, splenocytes
were analyzed by FACS® for the expression of activation markers as indi-
cated. Shaded histograms represent controls and unshaded histograms the
induced mutants. FSC, forward scatter.1159 Hao and Rajewsky
pes simplex thymidine kinase-transgenic mice (17), or anti-
bodies to IL-7 (19) or IL-7R (20), which all block B cell
generation in the BM to various extents. However, these
experiments suffered from the severe side effects of the
chemical drugs and the necessity of continuous treatment
of the animals in case of the anti–IL7 and anti–IL-7R anti-
bodies, such that the latter experiments were performed
over only short time periods. Another approach consisted
of the transfer of mature B cells into immunodeficient, syn-
geneic hosts (41, 42). These experiments are limited by the
amounts of cells that can be transferred, and, as an addi-
tional potential problem besides the cell transfer as such, in
part involved X-irradiation of the hosts (42). The results
obtained are still relevant for the present work as further
discussed below.
The experimental system described in the present paper
was developed to allow the induced ablation of B and T
cell generation under quasi-physiological conditions in in-
Figure 6. Proliferative activ-
ity of peripheral splenic B cells
revealed by BrdU-labeling and
cell cycle analysis. RAG-2fl/del,
Mx-cre mice, and littermate were
treated with Poly(I)·Poly(C) at
the age of 8 wk (A) or with type I
IFN at the age of 2 wk (B). 10
and 6 wk after induction, respec-
tively, the mice were fed with
BrdU in the drinking water for
3 d. At the end of the third day,
MZ and FO B cells were sorted,
fixed, and stained with anti-
BrdU antibody and propidium
iodide. One representative ex-
periment of two to four is
shown. Numbers indicate the
percentage of BrdU-positive
cells or cells in G1/G0, and S
and G2/M phase, respectively.1160 Homeostasis of Peripheral B Lymphocytes
tact mice. The transgenic mice carry a deleted and a loxP-
flanked allele of RAG-2, in combination with the Mx-Cre
transgene (34) from which Cre-recombinase can be ex-
pressed upon stimulation by IFN or its inducer Poly
(I)·Poly (C). In the absence of induction, B and T cell de-
velopment proceed normally in these mice; upon Cre in-
duction and RAG-2 deletion, development is blocked, and
we show that in the case of B cell development in the BM,
the developmental block is indeed complete. While it is
difficult to formally demonstrate that the system is abso-
lutely tight in all parts of the body, its efficiency is further
supported by the finding that in 62-wk-old animals in
which RAG-2 had been deleted at birth, only B-1 and vir-
tually no B-2 cells could be detected in the spleen (unpub-
lished data). Thus, in this system B cell development can be
ablated at any point in time, and the composition of the
peripheral B cell pool monitored thereafter.
Cre induction in the mutant mice also leads to an abla-
tion of T cell development. The consequence of this for
the peripheral T cell pool will be described in detail else-
where. However, we mention a few points here which are
relevant in this context. Thus, in adult mice, induced
RAG-2 inactivation also results in a decline of peripheral T
cell numbers, but the decline is less pronounced than in the
case of B cells, and the cells do not acquire an activated
phenotype. When T cell development is blocked at birth,
peripheral T cells are generated in normal numbers for the
first 3 weeks, probably because RAG-2 deletion is not fully
efficient in the thymus. Thereafter, T cell numbers slowly
decrease, but again we do not observe the generalized cel-
lular activation, as it is seen in the B cell compartment of
these animals (unpublished data). We thus see no reason to
suspect that the blockade of T cell development leads to a
situation in which the remaining T cells affect B cell ho-
meostasis in some unusual way. However, we are still in-
terested to assess B cell homeostasis in the present system in
the total absence of T cells, an experiment that will require
the introduction of further targeted mutations and thus ex-
tensive mouse crossing. The persistence of T cells in the
experimental animals is likely responsible for the presence
of T cell–dependent antibody isotypes in their blood.
While the present experimental system approaches what
it was intended for, namely a block of B and T cell genera-
tion under quasi-physiological conditions, it should still be
kept in mind that it involves short-term treatment of the
animals with type I IFN or Poly (I)·Poly (C), compounds
which are potent activators of the immune system. How-
ever, we have not observed any long-term effects of these
inducers on the homeostasis of the B and T cell compart-
ments in control animals (see also the present results).
Gradual Loss of FO, but Maintenance of MZ and B-1 B Cells
in Adult Mice upon RAG-2 Deletion. When B cell genera-
tion was blocked in adult mice, the immature B cells were
rapidly lost from BM and spleen, as expected. Mature B
cells also declined slowly over time, but the decline differed
for the various B cell subsets and anatomical locations:
there was a severe loss of B cells ( 90%) from the inguinal
lymph nodes over a 17-wk period, and the cells then per-
Figure 7. Serum immunoglobulin levels and numbers of IgM and
IgG3 secreting cells in mice having undergone RAG-2 deletion at birth.
Immunoglobulin levels in the sera of mice in which RAG-2 had been de-
leted at birth were measured by ELISA at the age of 8 wk (A) and 17 wk
(B). Numbers of IgM and IgG3 secreting cells in the spleen and BM (one
femur) of individual 8-wk-old mutant mice and littermate controls were
determined by ELISPOT (C). Dashes indicate geometric means.1161 Hao and Rajewsky
sisted in this environment for at least 54 wk, perhaps on the
basis of a homeostatic mechanism. In the spleen, FO B cells
declined to a similar extent over the 54-wk period, but the
decline was constant over time with a calculated half-life of
4.5 mo. This half-life is close to that determined for the
population of recirculating B cells in the BM ( 5 mo),
supporting the view that these cells are in equilibrium with
the splenic FO cells. Given that the FO B cells represent
the largest B cell subset in the spleen, it is likely that the
half-life of 4.5 mo truly reflects the average life span of
those cells, although it cannot be excluded that some FO B
cells convert to MZ B cells whose persistence over time
could be due to cellular influx from the FO B cell com-
partment. However, the maintenance of MZ B cells as well
as of the B1 cells in spleen and peritoneal cavity over the 54
wk of observation more likely indicates that MZ B cells,
like B1 cells (5), represent a self-renewing population, a
possibility that is supported by the analysis of mice in which
RAG-2 had been deleted at birth (see below). Overall, the
results attribute long life spans to most peripheral mature B
cells in the absence of B cell influx from the BM, but
clearly indicates that the subsets of MZ and B-1 B cells are
more stable under these conditions than the majority of FO
B cells (which seems to decline in spleen and lymph nodes
with different kinetics, for reasons that remain to be ex-
plored) and can presumably persist without decline for life-
time, at the population level. Influx of B cells from the BM
should result in shorter life spans of (some) peripheral ma-
ture cells, as is indeed suggested by earlier BrdU labeling
experiments (24–26).
When B Cell Generation Is Blocked at Birth, Activated B
Cells Persist in the Animals, and a Large Compartment of
Plasma Cells Is Generated. Only small numbers of B cells
are present in newborn mice. Many of these cells seem to
belong to the B-1 subset (43), and they express a restricted
antibody repertoire due to the paucity of N nucleotide in-
sertions and other special features of V(D)J recombination
predominating at this stage of development (1). There is
also evidence that the antibody repertoire of B cells in the
newborn is biased toward the production of “natural”
polyreactive antibodies prone to autoreactivity (44). How
do these B cells develop over time in the absence of subse-
quent influx of cells expressing a more diverse antibody
repertoire as it is typical for the adult mouse?
Upon RAG-2 deletion at birth, the animals maintain a
small, only slightly increasing B cell population for the 28-
wk period of observation and thus presumably for lifetime.
These cells assume an activated phenotype and resemble in
their majority B-1 and MZ B cells. Similar to B-1 cells (5),
the latter exhibit self-renewing capacity as indicated by
BrdU incorporation in vivo ( 10% of the cells incorporat-
ing label over a 3-d period). With respect to cellular activa-
tion, these results are strikingly similar to those of a recent
study of B cell development in IL-7–deficient mice (45). In
these animals B cells are generated only in the first 7 wk of
life and are maintained with a similar phenotype as in the
induced RAG-2 knockouts described above. In both sys-
tems large compartments of peritoneal B-1 cells and anti-
body secreting cells are generated, similar or greater in size
compared with those of wild-type animals.
These results are in good accord with observations made
in immunodeficient and/or irradiated mice reconstituted
with small numbers of mature, peripheral B cells. In such
animals B cells persisted at levels comparable to those seen
in the present study (41, 42). These cells also displayed an
activated phenotype and gave rise to a large compartment
of plasma cells from which normal levels of serum antibod-
ies are generated (42). A quick and efficient reconstitution
of the B-1 compartment including B-1–derived plasma
cells is also seen in such experimental models (46).
Whether the cells we see self-propagating in the animals
in which B cell development was blocked at birth belong
to a separate “fetal” lineage as has been postulated (39, 43,
47) is not addressed by the present experiments, although
the results are compatible with such a notion. Be this as it
may, the results directly demonstrate in the intact animal a
principle that has recently emerged mainly from cell trans-
fer experiments (42), namely that when B cell numbers are
limiting, the system preferentially propagates and maintains
activated and/or highly responsive cells (as shown for MZ
B cells in reference 6), from which a normal size or even
increased compartment of antibody secreting cells is gener-
ated. It will be of interest to elucidate the mechanisms by
which these cells and their antibody repertoire are selected,
and in particular to what extent (self-) antigens are involved
in this process as positive regulators. Recent experiments
(48) have indeed directly demonstrated positive selection of
B-1 cells by an autoantigen.
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